AHCO · AdaptHealth Corp.
$6.06
+3.59% last session
End-of-day data · close of 2026-09-11
Market cap
$1B
Enterprise value
$3B
Trailing P/E
—
Forward P/E
-45.7
Dividend yield
—
Beta
1.39
Avg volume
3M
Employees
11K
Daily Change %
3.59%
5 Days Change
-12.17%
10 Days Change
1.97%
30 Days Change
0.88%
60 Days Change
-44.23%
Month to Day Change
3.45%
Year to Day Change
-42.77%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — AHCO
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-06
Latest call per bank · past 12 months
UBS
Buy$10.00
+70.9% vs priceRBC Capital
Outperform$8.00
+36.8% vs priceJefferies
Buy$13.00
+122.2% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-06 | UBS | Maintains | Buy | $14.00 → $10.00 |
| 2026-08-06 | RBC Capital | Maintains | Outperform | $15.00 → $8.00 |
| 2026-08-05 | Truist Securities | Maintains | Buy | $14.00 → $9.00 |
| 2026-07-21 | Jefferies | Upgrade | Hold → Buy | $11.00 → $13.00 |
| 2026-07-06 | Baird | Maintains | Outperform | $18.00 → $15.00 |
| 2026-05-11 | RBC Capital | Maintains | Outperform | $13.00 → $15.00 |
| 2026-05-06 | Canaccord Genuity | Maintains | Buy | $14.00 → $16.00 |
| 2026-05-06 | UBS | Maintains | Buy | $15.00 → $14.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 44 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 23.8% below the 50-day MA ($7.95).
- Price vs 200-day MA: Trading 38.9% below the 200-day MA ($9.92).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is positive (+0.19) — short-term momentum is improving.
- 52-week range: Price sits between the 52-week low ($5.22) and high ($13.38).
AHCO Price Chart
Loading chart for AHCO…
Fundamentals
About AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.
More in Medical Devices
ABT
Abbott Laboratories
$179B -14.4% YTD
MDT
Medtronic plc.
$117B -2.7% YTD
SYK
Stryker Corporation
$104B -21.2% YTD
BSX
Boston Scientific Corporation
$62B -52.8% YTD
EW
Edwards Lifesciences Corporatio
$50B 1.1% YTD
DXCM
DexCom, Inc.
$32B 26.4% YTD
GEHC
GE HealthCare Technologies Inc.
$29B -20.4% YTD
PHG
Koninklijke Philips N.V. NY Reg
$24B -4.0% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.